Salk Institute Secures Up to $41.3M from ARPA-H to Pioneer Noninvasive Sonogenetic Therapies
In a groundbreaking advancement poised to revolutionize therapeutic interventions, Sreekanth Chalasani, PhD, a leading neuroscientist at the Salk Institute, has ...
